Using high quality HTS automated patch clamp data from human cardiac ion channels and in silico action potential modelling to cost-effectively predict QP prolongation and arrhythmia risk for CiPA
Presentation
Webinar title
Using high quality HTS automated patch clamp data from human cardiac ion channels and in silico action potential modelling to cost-effectively predict QP prolongation and arrhythmia risk for CiPA.
Summary
Presentation by Marc Rogers (Metrion CSO) at the September 2015 Safety Pharmacology Society, Prague.
The CiPA initiative – how it will change the way we do drug development in the future. Using high quality HTS automated patch-clamp data from human cardiac ion channels and in silico action potential modelling to cost–effectively predict QT prolongation and arrhythmia risk for CiPA
Speaker
Chief Scientific Officer
Metrion Biosciences
Dr Marc Rogers
Marc is a trained neuroscientist with 25 years’ experience in the patch-clamp technique from a number of prestigious international universities and 12 years of drug discovery on both sides of the Atlantic. He was an early adopter of automated patch-clamp platforms for ion channel screening and has an excellent knowledge of this market and connections with many of the commercial vendors.
Other recommended publications
White papers
Application notes
Let’s work together
What are your specific ion channel and assay needs?
If you have any questions or would like to discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.